Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: MCHP stock price vs ZBRA: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ZBRA's multiple
Needs Annual EPS, ZBRA P/E.
Implied fair value · at MCHP's multiple
Needs Annual EPS, MCHP P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Higher is better
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
MICROCHIP TECHNOLOGY INC · implied price per share
Reporting currency could not be verified.
ZEBRA TECHNOLOGIES CORP · implied price per share
Reporting currency could not be verified.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
MCHP · not enough data.
ZBRA · not enough data.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
INTEL CORP
MCHP vs INTC
TEXAS INSTRUMENTS INC
MCHP vs TXN
ADVANCED MICRO DEVICES INC
MCHP vs AMD
QUALCOMM INC/DE
MCHP vs QCOM
APPLIED MATERIALS INC /DE
MCHP vs AMAT
SKYWORKS SOLUTIONS, INC.
MCHP vs SWKS
NEXTERA ENERGY INC
MCHP vs NEE
COGNEX CORP
MCHP vs CGNX
Walgreens Boots Alliance, Inc.
MCHP vs WBA
Avery Dennison Corp
MCHP vs AVY
Leidos Holdings, Inc.
MCHP vs LDOS
MICRON TECHNOLOGY INC
MCHP vs MU
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe MCHP can sharply improve ROIC and sustain margin expansion enough to justify a 341.9x P/E, then hold or buy; otherwise, the data favors avoiding MCHP versus ZBRA because MCHP is priced at a steep premium despite weaker returns on capital and higher leverage.
MCHP trades at a very large premium to ZBRA on both earnings and sales, yet the model implies a much lower fair value than the current share price. The valuation gap is driven by MCHP’s much richer P/E, P/S, EV/EBITDA, and EV/Revenue multiples despite weaker ROIC and lower net margin than ZBRA.
Supporting Metrics
